-
3
-
-
84875704768
-
Prioritization of systematic reviews leads prioritization of research gaps and needs
-
Nasser M,Welch V. Prioritization of systematic reviews leads prioritization of research gaps and needs. J Clin Epidemiol. 2013;66(5):522-523.
-
(2013)
J Clin Epidemiol.
, vol.66
, Issue.5
, pp. 522-523
-
-
Nasser, M.1
Welch, V.2
-
4
-
-
0344665574
-
Measuring health in a vacuum: Examining the disability weight of the DALY
-
Reidpath DD, Allotey PA, Kouame A, Cummins RA. Measuring health in a vacuum: examining the disability weight of the DALY. Health Policy Plan. 2003;18(4):351-356.
-
(2003)
Health Policy Plan.
, vol.18
, Issue.4
, pp. 351-356
-
-
Reidpath, D.D.1
Allotey, P.A.2
Kouame, A.3
Cummins, R.A.4
-
6
-
-
84871051576
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
-
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2163-2196
-
-
Vos, T.1
Flaxman, A.D.2
Naghavi, M.3
et al.4
-
7
-
-
84871047327
-
GBD 2010: Design, definitions, and metrics
-
Murray CJ, EzzatiM, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2063-2066
-
-
Murray, C.J.1
Ezzati, M.2
Flaxman, A.D.3
et al.4
-
8
-
-
84900812974
-
The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions
-
Hay RJ, Johns NE,Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2013. doi:10.1038/jid.2013.446.
-
(2013)
J Invest Dermatol.
-
-
Hay, R.J.1
Johns, N.E.2
Williams, H.C.3
et al.4
-
9
-
-
77954750707
-
Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting
-
ClarkeM, Hopewell S, Chalmers I. Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet. 2010;376(9734):20-21.
-
(2010)
Lancet
, vol.376
, Issue.9734
, pp. 20-21
-
-
Clarke, M.1
Hopewell, S.2
Chalmers, I.3
-
10
-
-
84908256651
-
-
Accessed November 21, 2013
-
The Cochrane Collaboration. About the Cochrane Library. http://www.thecochranelibrary .com/view/0/AboutTheCochraneLibrary .html#CDSR. Accessed November 21, 2013.
-
About the Cochrane Library
-
-
-
11
-
-
0032527547
-
Methodology and reports of systematic reviews and meta-analyses: A comparison of Cochrane reviews with articles published in paper-based journals
-
Jadad AR, Cook DJ, Jones A, et al.Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA. 1998;280 (3):278-280.
-
(1998)
JAMA
, vol.280
, Issue.3
, pp. 278-280
-
-
Jadad, A.R.1
Cook, D.J.2
Jones, A.3
et al.4
-
12
-
-
33947684405
-
Epidemiology and reporting characteristics of systematic reviews
-
Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med. 2007;4(3):e78.
-
(2007)
PLoS Med.
, vol.4
, Issue.3
, pp. e78
-
-
Moher, D.1
Tetzlaff, J.2
Tricco, A.C.3
Sampson, M.4
Altman, D.G.5
-
13
-
-
33750921286
-
Cochrane Skin Group systematic reviews are moremethodologically rigorous than other systematic reviews in dermatology
-
Collier A, Heilig L, Schilling L,Williams H, Dellavalle RP. Cochrane Skin Group systematic reviews are moremethodologically rigorous than other systematic reviews in dermatology. Br J Dermatol. 2006;155(6):1230-1235.
-
(2006)
Br J Dermatol.
, vol.155
, Issue.6
, pp. 1230-1235
-
-
Collier, A.1
Heilig, L.2
Schilling, L.3
Williams, H.4
Dellavalle, R.P.5
-
14
-
-
84908255383
-
-
Accessed December 5, 2013
-
The Cochrane Collaboration. About Cochrane systematic reviews and protocols. http://www.thecochranelibrary.com/view/0/AboutCochraneSystematicReviews.html. Accessed December 5, 2013.
-
About Cochrane Systematic Reviews and Protocols
-
-
-
15
-
-
84908244028
-
-
Accessed November 1, 2013
-
The Cochrane Collaboration. Search the Cochrane Library. http://www.thecochranelibrary .com/view/0/index.html. Accessed November 1, 2013.
-
Search the Cochrane Library
-
-
-
16
-
-
84871047327
-
GBD 2010: Design, definitions, and metrics
-
Murray CJ, EzzatiM, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2063-2066
-
-
Murray, C.J.1
Ezzati, M.2
Flaxman, A.D.3
et al.4
-
19
-
-
60549094452
-
An update on acute and chronic urticaria for the primary care provider
-
Najib U, Sheikh J. An update on acute and chronic urticaria for the primary care provider. Postgrad Med. 2009;121(1):141-151.
-
(2009)
Postgrad Med.
, vol.121
, Issue.1
, pp. 141-151
-
-
Najib, U.1
Sheikh, J.2
-
20
-
-
0034746255
-
Understanding pruritus in systemic disease
-
Krajnik M, Zylicz Z. Understanding pruritus in systemic disease. J Pain SymptomManage. 2001;21 (2):151-168.
-
(2001)
J Pain SymptomManage.
, vol.21
, Issue.2
, pp. 151-168
-
-
Krajnik, M.1
Zylicz, Z.2
-
21
-
-
84858627615
-
Scabies in the developing world - Its prevalence, complications, and management
-
Hay RJ, Steer AC, Engelman D,Walton S. Scabies in the developing world - its prevalence, complications, and management. Clin Microbiol Infect. 2012;18(4):313-323.
-
(2012)
Clin Microbiol Infect.
, vol.18
, Issue.4
, pp. 313-323
-
-
Hay, R.J.1
Steer, A.C.2
Engelman, D.3
Walton, S.4
-
23
-
-
68949149916
-
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 4, guidelines of care for the management and treatment of psoriasis with traditional systemic agents
-
Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4, guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J AmAcad Dermatol. 2009;61(3):451-485.
-
(2009)
J AmAcad Dermatol.
, vol.61
, Issue.3
, pp. 451-485
-
-
Menter, A.1
Korman, N.J.2
Elmets, C.A.3
et al.4
-
24
-
-
0038104272
-
Prevalence of joint disease in patients with psoriasis: Implications for therapy
-
Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4(7):441-447.
-
(2003)
Am J Clin Dermatol.
, vol.4
, Issue.7
, pp. 441-447
-
-
Zachariae, H.1
-
25
-
-
0021723357
-
Ophthalmological manifestations in patients with psoriasis
-
Catsarou-Catsari A, Katsambas A, Theodoropoulos P, Stratigos J. Ophthalmological manifestations in patients with psoriasis. Acta Derm Venereol. 1984;64(6):557-559.
-
(1984)
Acta Derm Venereol.
, vol.64
, Issue.6
, pp. 557-559
-
-
Catsarou-Catsari, A.1
Katsambas, A.2
Theodoropoulos, P.3
Stratigos, J.4
-
26
-
-
84888774024
-
Risk of moderate to advanced kidney disease in patientswith psoriasis: Population-based cohort study
-
Wan J,Wang S, Haynes K, DenburgMR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patientswith psoriasis: population-based cohort study. BMJ. 2013;347:f5961.
-
(2013)
BMJ
, vol.347
, pp. f5961
-
-
Wan, J.1
Wang, S.2
Haynes, K.3
Denburg, M.R.4
Shin, D.B.5
Gelfand, J.M.6
-
28
-
-
84908234616
-
-
Accessed February 16, 2014
-
The Cochrane Collaboration. Cochrane agenda and priority settingmethods group. http://capsmg .cochrane.org/approaches-used-cochrane -review-groups-prioritization. Accessed February 16, 2014.
-
Cochrane Agenda and Priority Settingmethods Group
-
-
-
30
-
-
33845243126
-
Improving the use of research evidence in guideline development, 2: Priority setting
-
Oxman AD, Schünemann HJ, Fretheim A. Improving the use of research evidence in guideline development, 2: priority setting. Health Res Policy Syst. 2006;4:14.
-
(2006)
Health Res Policy Syst.
, vol.4
, pp. 14
-
-
Oxman, A.D.1
Schünemann, H.J.2
Fretheim, A.3
-
32
-
-
84908225852
-
-
Accessed November 21, 2013
-
Cochrane Skin Group.Howare titles prioritized? http://skin.cochrane.org/titles. Accessed November 21, 2013.
-
Howare Titles Prioritized?
-
-
-
33
-
-
80155135721
-
ReDD-observatory: Using the web of data for evaluating the research-disease disparity
-
Presented at August 22-27, Lyon, France
-
Zaveri A, Pietrobon R, Auer S, Lehmann J, Martin M, Ermilov T. ReDD-observatory: using the web of data for evaluating the research-disease disparity. Presented at the 2011 IEEE/WIC/ACM International Conference onWeb Intelligence; August 22-27, 2011; Lyon, France.
-
(2011)
The 2011 IEEE/WIC/ACM International Conference OnWeb Intelligence
-
-
Zaveri, A.1
Pietrobon, R.2
Auer, S.3
Lehmann, J.4
Martin, M.5
Ermilov, T.6
-
35
-
-
84871036375
-
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010 [supplementary appendix]
-
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [supplementary appendix]. Lancet. 2012;380 (9859):2095-2128.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2095-2128
-
-
Lozano, R.1
Naghavi, M.2
Foreman, K.3
et al.4
|